Sign in
4

Changes in Ownership

Pharvaris N.V. Filed Acc 0001193125-26-201906

Chief Medical Officer sold 18,733 shares at an average $30.21 ($565,859)

  • Chief Medical Officer acquired 18,733 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lu Peng · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2026-04-29 Exercise or conversion : show line 1 in the form 10b5-1 +3,733 $2.59 $9,668 69,816 D
2026-04-29 Sale : show line 2 in the form 10b5-1 −3,733 $30.06 $112,232 62,350 D
2026-04-30 Exercise or conversion : show line 3 in the form 10b5-1 +15,000 $2.59 $38,850 81,083 D
2026-04-30 Sale : show line 4 in the form 10b5-1 −15,000 $30.24 $453,627 66,083 D
Open-market sales · 18,733 sh · avg $30.21 · $565,859

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-04-29 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (Right to Buy) −3,733 234,474 D
2026-04-30 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (Right to Buy) −15,000 219,474 D
Loading xslF345X06/ownership.xml…